Matli Mputsoe Scatino

perfect start

[Dr. Eric Berg DC @dr_ericberg]

Cloves were once worth MORE than gold.

This tiny spice has been used for centuries, yet most people don’t know what it contains or how it’s traditionally used.

Here are 7 benefits of drinking clove water before bed: 🧵

[Nicolas Hulscher, MPH @NicHulscher]

This should be front-page news EVERYWHERE…

A new study found taking just 4 Tylenol tablets during pregnancy is linked to SERIOUS REPRODUCTIVE DAMAGE in baby girls:

13% SMALLER uteruses
23% FEWER ovarian follicles
41% SMALLER ovaries

This is very worrisome given that over 50% of pregnant women take Tylenol….

[Dr. Steven Hopkins @drstevenhopkins]

🚨BREAKING: THE LARGEST IVERMECTIN CANCER STUDY IN HISTORY JUST DROPPED A BOMBSHELL! Nearly HALF of desperate cancer patients achieved COMPLETE REMISSION /dramatic TUMOR REGRESSION in just 6 months, while the Chemo Cartel scrambles to bury the truth
#Cancer
#protocol
#ivermectin

[Nicolas Hulscher, MPH @NicHulscher]

Nattokinase SHRANK PLAQUE in clogged arteries by 36% in TWO human studies.

Two separate studies, nearly IDENTICAL results.

The dose is critical: at least 6,000 FU/day was needed to shrink arterial plaque.

Lower doses of 2,000–3,600 FU/day were ineffective.

[Dr. David Martin @DrDMartinWorld]

A deeply critical letter arising from a brotherhood of men with whom I am working very closely on healing ourselves. https://t.co/KXGZAxhYNj

[Dr. David Martin @DrDMartinWorld]

Make sure you watch and share with @RWMaloneMD and listen to the @KenPaxtonTX review. https://t.co/gYgHtn5Vvv

[William Makis MD @MakisMedicine]

NEW ARTICLE: IVERMECTIN, MEBENDAZOLE, HYDROXYCHLOROQUINE Testimonial - 68 year old woman in Poland with Multiple Myeloma reports after 6 months

Ivermectin Revolution is sweeping into POLAND! 🇵🇱

STORY:
68 year old woman in Poland with Multiple Myeloma and two osteolytic lesions in T11 and L3.

In December she started:
Ivermectin 1mg/kg/day
Fenbendazole 1500mg/day

In January she added:
Hydroxychloroquine 400mg/day

In February she added:
Mebendazole 1500mg/day

Results after 6 months:

Lambda free light chains 44.92 (N 5.7-26.3) dropped to Normal

"Her latest serum protein electrophoresis shows no obvious monoclonal spike on electrophoresis tracing.

"She is feeling very well at the moment"

The use of repurposed drugs in hematological cancers is now being explored, as the use of Ivermectin was first published in Leukemia in children in 2020.

Hydroxychloroquine use in Cancer is a novel idea with an explosion of recent research and Pubmed showing over 1000 results (published studies)...

The irrational psychotic hate of Ivermectin by some doctors is completely misplaced. The cutting edge use of repurposed drugs in Cancer goes way beyond Ivermectin! 😃

I have helped over 9000 Cancer patients with Ivermectin, Mebendazole and Fenbendazole in the largest "Right to Try" Research project in the world.

[RXMEDS.STORE @rxmeds_store]

🚨 FENBENDAZOLE VS MEBENDAZOLE: WHICH ONE FOR WHICH CANCER? DR. WILLIAM MAKIS EXPLAINS

🧬 Two antiparasitic medicines. Different cancer types. And one key question: if you have a choice, which one does Dr. William Makis highlight for each?

His first answer is straightforward:

“Whichever one you can get.”

In some countries, mebendazole is readily available. In others, fenbendazole is cheaper and easier to access. Many people can get one or the other, but not both.

But if you have the luxury of choice, Dr. Makis says the type of cancer becomes an important part of the discussion.

💊 MEBENDAZOLE: BRAIN TUMORS & SQUAMOUS CELL CANCERS

Dr. Makis highlights mebendazole for several cancer types:

✅ Brain tumors: Glioblastomas and astrocytomas
✅ Brain metastases: Including those originating from lung cancer or triple-negative breast cancer
✅ Head and neck cancers: Most are squamous cell carcinomas
✅ Cervical squamous cell carcinoma
✅ Esophageal squamous cell carcinoma
✅ Certain squamous cell carcinomas of the prostate and rectum
✅ Breast cancer

One reason he emphasizes mebendazole for brain tumors is its ability to cross the blood-brain barrier better than fenbendazole or ivermectin.

💊 FENBENDAZOLE: ADENOCARCINOMAS

For fenbendazole, Dr. Makis points to adenocarcinomas, cancers that develop from glandular tissue.

His examples include:

✅ Prostate adenocarcinoma
✅ Lung adenocarcinoma
✅ Pancreatic adenocarcinoma

These are the key distinctions he makes when comparing the two medicines.

⁉️ SO, WHICH ONE SHOULD YOU KNOW ABOUT?

Dr. Makis's main point is simple: availability often determines which medicine people can access, but when both are available, he draws a distinction based on cancer type.

His comparison puts two familiar antiparasitic medicines at the center of an ongoing conversation about drug repurposing and their potential applications.

The search for new possibilities starts with asking better questions. Understanding fenbendazole, mebendazole, and the different areas being explored gives people more to learn about this evolving field.

📌 SAVE this breakdown so you can easily revisit the key differences between fenbendazole and mebendazole.

🔄 REPOST to help others discover Dr. Makis’s comparison and join the conversation about fenbendazole, mebendazole, and drug repurposing.

💊 Looking for fenbendazole or mebendazole? Explore quality options at @rxmeds_store, with worldwide delivery.

#Fenbendazole #Mebendazole #CancerResearch #DrugRepurposing #Glioblastoma #Adenocarcinoma

[Nicolas Hulscher, MPH @NicHulscher]

🚨BREAKING: The Most Comprehensive Ivermectin–Mebendazole Cancer Paper to Date Finds 37 Distinct Anticancer Mechanisms Across 25 Human Cancer Types

We synthesized DECADES of evidence from over a HUNDRED studies, revealing one of the BROADEST repertoires of anticancer mechanisms ever documented for an off-patent drug combination:

IVERMECTIN: 29 distinct anticancer mechanisms across 20 human cancer types.

MEBENDAZOLE: 26 distinct anticancer mechanisms across 17 human cancer types.

COMBINED: 37 distinct mechanism classes across 25 human cancer types in preclinical research.

Across laboratory and animal studies, ivermectin and mebendazole have demonstrated multiple overlapping and complementary anticancer mechanisms:

• Disrupt cancer-cell division
• Trigger programmed cancer-cell death
• Interfere with tumor energy production
• Inhibit tumor blood-vessel formation
• Suppress cancer-cell growth signaling
• Target cancer stem-like cells
• Interfere with metastatic spread
• Modulate antitumor immune responses
• Disrupt cancer-associated DNA repair pathways
• Counter multidrug-resistance mechanisms
• Enhance sensitivity to certain chemotherapies
• Influence pathways involved in radiation resistance

This is a REMARKABLE breadth of anticancer mechanisms for two inexpensive, off-patent drugs—spanning nearly every major hallmark of cancer biology.

The landmark 44-page scientific paper was produced by our research team at the McCullough Foundation and The Wellness Company.

Importantly, both compounds have decades of human use, established manufacturing infrastructure, well-characterized pharmacology, and low generic-drug costs.

The data can NO LONGER be ignored. The scientific case for launching large clinical trials is stronger than ever.

In the meantime, cancer patients will continue exercising their “right to try.”

@DrHarveyRisch @McCulloughFund @twc_health @P_McCulloughMD @PeterGillooly @jathorpmfm @DrKellyVictory

[William Makis MD @MakisMedicine]

BREAKING NEWS: NEVER EVER BUY IVERMECTIN ON X!

X is overrun with FRAUD
Same with Facebook, Telegram, WhatsApp, etc

[Nicolas Hulscher, MPH @NicHulscher]

STUDY: VITAMIN C + GRAPE SEED EXTRACT SHRUNK TUMORS BETTER THAN CHEMOTHERAPY IN VIVO

The nutraceutical combo produced 25% SMALLER TUMORS than the powerful chemotherapy drug doxorubicin (“RED DEVIL”) in a head-to-head animal study.

Tumor volume reduction vs. untreated controls (best to worst):

VITAMIN C + GRAPE SEED EXTRACT: 77% reduction (171.98 mm³)

DOXORUBICIN ("RED DEVIL"): 69% reduction (229.27 mm³)

GRAPE SEED EXTRACT ONLY: 63% reduction (269.14 mm³)

VITAMIN C ONLY: 57% reduction (316.69 mm³)

UNTREATED CONTROLS: 0% reduction (735.40 mm³)

[Valerie Anne Smith @ValerieAnne1970]

🚨THEY BURIED THIS FOR A REASON:

Hydroxychloroquine doesn’t just block viruses — it reprograms them into cancer hunters that zero in on tumor cells while leaving healthy ones untouched.

One of America's Frontline Doctors, Dr. Richard Urso exposes the truth. The real question: why was every trace of this research suppressed and ridiculed?

A dirt-cheap, decades-old drug that could selectively destroy cancer would obliterate the multi-trillion-dollar oncology cash machine overnight.

They don’t want cures. They want lifetime customers paying for toxic chemo, radiation, and “new” drugs that cost hundreds of thousands.

This information was deliberately buried.
The truth is leaking out again.

[RXMEDS.STORE @rxmeds_store]

🚨 “CANCER IS NO LONGER A DEATH SENTENCE.” DR. WILLIAM MAKIS ON IVERMECTIN, MEBENDAZOLE & FENBENDAZOLE IN CANCER RESEARCH

What if the future of cancer treatment includes looking at existing medicines in entirely new ways?

Dr. William Makis, a Canadian physician specializing in nuclear medicine, radiology and oncology, believes repurposed drugs deserve serious attention in the fight against cancer.

💊 THREE MEDICINES AT THE CENTER OF THE DISCUSSION

Makis highlights three antiparasitic medications he says he has incorporated into approaches discussed with cancer patients:

• Ivermectin
• Mebendazole
• Fenbendazole

His broader message is that researchers should keep investigating whether existing medicines could offer new possibilities for patients facing difficult cancer diagnoses.

🔬 WHY IVERMECTIN & MEBENDAZOLE?

One particularly intriguing area is chemosensitization.

Makis points to preclinical research investigating whether ivermectin and mebendazole can make cancer cells more vulnerable to chemotherapy, potentially helping chemotherapy kill them more efficiently.

⚡ FROM LABORATORY FINDINGS TO NEW POSSIBILITIES

The idea is compelling: rather than studying every compound in isolation, researchers can investigate how existing medicines interact with cancer biology and established treatments.

But laboratory findings are only the beginning. Clinical trials are needed to determine whether these combinations are safe and improve outcomes for patients.

📢 THE MESSAGE THAT MATTERS

A cancer diagnosis can leave patients and families searching desperately for answers. Research into drug repurposing represents another avenue worth investigating, with the ultimate goal of finding better treatments, extending lives and giving patients more hope.

The mission is clear: keep researching, keep asking questions and keep pushing for better options for cancer patients.

📌 SAVE this post to revisit the research.

🔄 REPOST to help more people discover the growing discussion around drug repurposing in oncology.

💊 Looking for pharmaceutical-grade medications? Explore ivermectin, fenbendazole, mebendazole and more at @rxmeds_store, with worldwide delivery.

#CancerResearch #Ivermectin #Mebendazole #Fenbendazole #DrugRepurposing #Oncology #DrMakis

[William Makis MD @MakisMedicine]

Always love talking with @RedactedNews!! 😃

[Dr. David Martin @DrDMartinWorld]

Enjoy this and share...https://t.co/GYBemYnfvl

[Nicolas Hulscher, MPH @NicHulscher]

This new study is insane…

ENOKI MUSHROOM extract just SUPPRESSED cancer growth by 99.8%.

Tumors COMPLETELY DISAPPEARED in 67% of mice.

Immune system macrophage counts INCREASED by 166%.

The mushroom was administered for just 10 DAYS.

Human studies are URGENTLY WARRANTED.

[Aaron Siri @AaronSiriSG]

Discussing why the claim “vaccines do not cause autism” is a tenet of faith, not a statement of fact.

[Dr. David Martin @DrDMartinWorld]

So this podcast might stir up a thing or two....https://t.co/Ng9vLLMlcu